Date added: 18 Mar 2014
2013 - Best Medical Technology product: S-ICD® System - Boston Scientific
Sudden Cardiac Death (SCD) occurs in approximately 350,000 patients annually in the United States. It is generally accepted that implantable cardioverter defibrillators (ICDs) have a demonstrable benefit in the prevention of SCD in patients secondary to a prior arrhythmic event. Furthermore, large clinical studies have demonstrated that prophylactic implantation of ICDs for primary prevention reduces mortality in subsets of patients.